WO2007142929A3 - Novel pde4 inhibitors - Google Patents
Novel pde4 inhibitors Download PDFInfo
- Publication number
- WO2007142929A3 WO2007142929A3 PCT/US2007/012668 US2007012668W WO2007142929A3 WO 2007142929 A3 WO2007142929 A3 WO 2007142929A3 US 2007012668 W US2007012668 W US 2007012668W WO 2007142929 A3 WO2007142929 A3 WO 2007142929A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitors
- pde4 inhibitors
- compounds
- disorders
- arthritis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PDE4 inhibitors, pharmaceutical compositions including the inhibitors, and methods of treatment using the inhibitors are disclosed. The compounds are illustrated by Formulas 1-9 in the specification. The compounds can be used to treat a variety of disorders mediated by phosphodiesterase, and TNF-α, including asthma, chronic bronchitis, chronic obstructive pulmonary disease, arthritis, respiratory distress syndrome, allergic rhinitis, neurogenic inflammation, pain, rheumatoid arthritis, central nervous system disorders, cardiovascular disorders, and tumor progression.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80975106P | 2006-05-31 | 2006-05-31 | |
US60/809,751 | 2006-05-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007142929A2 WO2007142929A2 (en) | 2007-12-13 |
WO2007142929A3 true WO2007142929A3 (en) | 2008-04-24 |
Family
ID=38801992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/012668 WO2007142929A2 (en) | 2006-05-31 | 2007-05-29 | Novel pde4 inhibitors |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101495454A (en) |
WO (1) | WO2007142929A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013155123A1 (en) | 2012-04-10 | 2013-10-17 | Georgia State University Research Foundation, Inc. | Compositions and methods for treating otitis media and other conditions with inhibitors of cyld |
US11446398B2 (en) | 2016-04-11 | 2022-09-20 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
CN107714686B (en) * | 2016-08-10 | 2020-01-14 | 广州华真医药科技有限公司 | Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of drugs for treating prostatic cancer hyperplasia and metastasis |
MX2019014960A (en) | 2017-06-12 | 2020-08-06 | Obsidian Therapeutics Inc | Pde5 compositions and methods for immunotherapy. |
US11891634B2 (en) | 2017-06-23 | 2024-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | PDE5A destabilizing domains |
JP2021535180A (en) * | 2018-09-05 | 2021-12-16 | ユニベルシテイト ファン アムステルダム | Use of PDE11 or PDE2 inhibitors for the treatment of Parkinson's disease |
CN109908139B (en) * | 2018-12-28 | 2022-02-22 | 南京市儿童医院 | Use of cilomilast for the preparation of a medicament for the treatment of a disorder associated with acute kidney injury |
CN110003102B (en) * | 2019-05-16 | 2022-03-22 | 河南师范大学 | (R) -2- (alpha-deuterium-alpha-alkyl-alpha-aromatic) nitrogen heteroaryl compound and preparation method and application thereof |
CN110279686A (en) * | 2019-08-01 | 2019-09-27 | 汪海涛 | A kind of phosphodiesterase 4 inhibitors are preventing and are treating the application in Parkinson's disease |
MX2022002747A (en) | 2019-09-10 | 2022-04-06 | Obsidian Therapeutics Inc | Ca2-il15 fusion proteins for tunable regulation. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4838930A (en) * | 1985-04-01 | 1989-06-13 | Ciba-Geigy Corporation | 3-fuoropyridyl-2-oxy-phenoxy derivatives having herbicidal activity |
-
2007
- 2007-05-29 CN CNA2007800286628A patent/CN101495454A/en active Pending
- 2007-05-29 WO PCT/US2007/012668 patent/WO2007142929A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4838930A (en) * | 1985-04-01 | 1989-06-13 | Ciba-Geigy Corporation | 3-fuoropyridyl-2-oxy-phenoxy derivatives having herbicidal activity |
Also Published As
Publication number | Publication date |
---|---|
CN101495454A (en) | 2009-07-29 |
WO2007142929A2 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007142929A3 (en) | Novel pde4 inhibitors | |
WO2007114848A3 (en) | Chemical compounds | |
WO2008115973A3 (en) | Aminopyrimidines useful as kinase inhibitors | |
WO2008137622A3 (en) | Aminopyrimidines useful as kinase inhibitors | |
WO2007056163A3 (en) | Aminopyrimidines useful as kinase inhibitors | |
WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
WO2007084557A3 (en) | Azaindoles useful as inhibitors of janus kinases | |
WO2008112651A3 (en) | Aminopyrimidines useful as inhibitors of protein kinases | |
WO2008137619A3 (en) | Thiazoles and pyrazoles useful as kinase inhibitors | |
WO2008116139A3 (en) | N-heterocyclic compounds useful as inhibitors of janus kinases | |
WO2008005303A3 (en) | Thiazolopyrimidine modulators of trpv1 | |
WO2005105780A3 (en) | Compositions useful as inhibitors of rock and other protein kinases | |
WO2008147626A3 (en) | Thiazoles and pyrazoles useful as kinase inhibitors | |
WO2007071313A3 (en) | Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases | |
WO2007095188A3 (en) | Dihydrodiazepines useful as inhibitors of protein kinases | |
EA201170005A1 (en) | DIAMINOPIRIDINE, PYRIMIDINE AND Pyridazine MODULATORS OF HISTAMINE RECEPTOR H | |
WO2008008359A3 (en) | Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor | |
NO20070319L (en) | Novel pyridazine-3 (2H) -one derivatives and their use as PDE4 inhibitors | |
WO2007076286A3 (en) | Chemical compounds | |
MX2009008787A (en) | 2-aminopyrimidine modulators of the histamine h4 receptor. | |
WO2007095223A3 (en) | Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases | |
MX2009010270A (en) | Indole carboxamides as ikk2 inhibitors. | |
NO20084411L (en) | Tetrahydro-pyrimidoazepines as modulators of TRPVI | |
WO2007015923A3 (en) | Benzimidazoles useful as inhibitors of protein kinases | |
WO2006083869A3 (en) | Tumor necrosis factor inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780028662.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07795453 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07795453 Country of ref document: EP Kind code of ref document: A2 |